Health Condition 1: K409- Unilateral inguinal hernia, without obstruction or gangrene
Conditions
Interventions
Intervention1: Group D1 - 15mgs(3ml) of 0.5% hyperbaric bupivacaine along with 3µgs of Inj. Dexmedetomidine: All the patients in Group D1 receive 15mgs(3ml) of 0.5% hyperbaric bupivacaine along with 3
Sponsors
Dr Gayathri Subhash Banasode
Dr Nisheed Joseph
Eligibility
Inclusion criteria
Inclusion criteria: 120 adult patients between the age group of 20-65yrs of physical status American Society of Anesthesiologists Physical Status I and II who undergo infra umbilical surgeries e.g.: Inguinal hernia repair surgeries, varicose vein surgeries, lower limb surgeries, etc.
Exclusion criteria
Exclusion criteria: Uncooperative patients, patients with uncontrolled hypertension, and diabetes, patients with allergy to the study drugs, patients on antiarrhythmics, beta-blockers, anticoagulants, ACE inhibitors, pregnant women, body weight >120kg, Heart Rate < 60 beats per minute and patients having a condition which is a contraindication to spinal anaesthesia such as patient refusal, infection at the site of injection, coagulopathy, increased intracranial pressure.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the pain after two different doses of dexmedetomidine 3µg and 5µg, as an additive to hyperbaric bupivacaine 0.5% via intrathecal route (Spinal).Timepoint: Baseline, 1st hour,2nd hour,4th hour and 6th hour. | — |
Secondary
| Measure | Time frame |
|---|---|
| Onset and duration of sensory and motor block, hemodynamic effects, duration of analgesia, and occurrence of side effects.Timepoint: 6 hours | — |
Countries
India
Contacts
Public ContactDr Gayathri Subhash Banasode
Kodagu Institute of Medical Sciences
Outcome results
None listed